Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 465-472

  Arenberg, Douglas A ^a   Keane, Michael P ^a   DiGiovine, Bruno ^a   Kunkel, Steven L ^b   Morris, Susan B ^a   Xue, Ying Ying ^a   Burdick, Marie D ^a   Glass, Mary C ^a   Iannettoni, Mark D ^b   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Angiogenesis; Apoptosis; Chemokines; Malignancy; Metastasis

Indexed keywords

EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; METASTASIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 17744406409     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3145     Document Type: Article

References (32)

1. Gimbrone, M.A., S.B. Leapman, R.S. Cotran, and J. Folkman. 1972. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136: 261-276.
2. Folkman, J. 1995. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333:1757-1763.
3. Strieter, R.M., P.J. Polverini, S.L. Kunkel, D.A. Arenberg, M.D. Burdick, J. Kasper, J. Dzuiba, J. Van Damme, A. Walz, D. Marriott, et al. 1995. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270:27348-27357.
4. Arenberg, D.A., S.L. Kunkel, P.J. Polverini, M. Glass, M.D. Burdick, and R.M. Strieter. 1996. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 97:2792-2802.
5. Smith, D.R., P.J. Polverini, S.L. Kunkel, M.B. Orringer, R.I. Whyte, M.D. Burdick, C.A. Wilke, and R.M. Strieter. 1994. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 179:1409-1415.
6. Arenberg, D.A., S.L. Kunkel, P.J. Polverini, S.B. Morris, M.D. Burdick, M. Glass, D.T. Taub, M.D. Iannetoni, R.I. Whyte, and R.M. Strieter. 1996. Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J. Exp. Med. 184:981-992.
7. Walz, A., R. Burgener, B. Car, M. Baggiolini, S.L. Kunkel, and R.M. Strieter. 1991. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J. Exp. Med. 174:1355-1362.
8. Strieter, R.M., S.L. Kunkel, M.D. Burdick, P.M. Lincoln, and A. Walz. 1992. The detection of novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Investig. 21:589-596.
9. Koch, A.E., J. Burrows, M. Cho, P.J. Polverini, and J. Leibovich. 1991. Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity. Agents Actions. 34:350-357.
10. Polverini, P.J., P.S. Cotran, M.A. Gimbrone, and E.R. Unanue. 1977. Activated macrophages induce vascular proliferation. Nature. 269:804-806.
11. Koch, A.E., S.J. Leibovich, and P.J. Polverini. 1989. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 29:471-479.
12. Standiford, T.J., S.L. Kunkel, M.A. Basha, S.W. Chensue, J.P. Lynch, G.B. Toews, J. Westwick, and R.M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
13. Weidner, N. 1995. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147:9-19.
14. O'Reilly, M., T. Boehm, Y. Shing, N. Fukai, G. Vasios, W. Lane, E. Flynn, J. Birkhead, B.R. Olsen, and J. Folkman. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:277-285.
15. O'Reilly, M.S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2:689-692.
16. Miller, M.D., and M.S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17-46.
17. Strieter, R.M., S.L. Kunkel, D.A. Arenberg, M.D. Burdick, and P.J. Polverini. 1995. Interferon gamma-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem. Biophys. Res. Commun. 210:51-57.
18. Koch, A.E., P.J. Polverini, S.L. Kunkel, L.A. Harlow, L.A. DiPietro, V.M. Elner, S.G. Elner, and R.M. Strieter. 1992. Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science. 258:1798-1801.
19. Hu, D.E., Y. Hori, and T.P.D. Fan. 1993. Interleukin-8 stimulates angiogenesis in rats. Inflammation. 17:135-143.
20. Angiolillo, A.L., C. Sgadari, D.T. Taub, F. Liao, J.M. Farber, S. Maheshwari, H.K. Kleinman, G.H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 158:155-162.
21. Luster, A.D., S.M. Greenberg, and P. Leder. 1995. The IP-10 chemokine binds to a specific eell surface heparan sulfate shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:219-232.
22. Maione, T.E., G.S. Gray, J. Petro, A.J. Hunt, A.L. Donner, S.I. Bauer, H.F. Carson, and R.J. Sharpe. 1990. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science. 247:77-79.
23. Bellocq, A., M. Antoine, A. Flauhault, C. Phillipe, B. Crestani, J. Bernaudin, C. Mayaud, B. Milleron, L. Baud, and J. Cadranel. 1998. Neutrophil alveolitis in bronchoalveolar carcinoma: induction by interleukin-8 and relation to clinical outcome. Am. J. Pathol. 152:83-92.
24. Kitadai, Y., K. Haruma, K. Sumii, S. Yamamoto, T. Ue, H. Yokozaki, W. Yasui, Y. Ohmoto, G. Kajiyama, I.J. Fidler, and E. Tahara. 1998. Expression of interleukin-8 correlates with vascularity in human gastric carcinoma. Am. J. Pathol. 152:93-100.
25. Desbaillets, I., A.C. Diserens, N. Tribolet, M.F. Hamou, and E.G. Van Meir. 1997. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 186:1201-1212.
26. Schadendorf, D., A. Moller, B. Algermissen, M. Worm, M. Sticherling, and B.M. Czarnetzki. 1993. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 153:2667-2675.
27. Singh, R.K., M. Gutman, R. Radinsky, C.D. Bucana, and I.J. Fidler. 1994. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54:3242-3247.
28. Luan, J., R. Shattuck-Brandt, H. Haghnegahdar, J.D. Owen, R. Strieter, M. Burdick, C. Nirodi, D. Beauchamp, K.N. Johnson, and A. Richmond. 1997. Mechanism and biological significance of constitutive expression of MGSA/ GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 62:588-597.
29. Owen, J.D., R. Strieter, M. Burdick, H. Haghnegahdar, L. Nanney, R. Shattuck-Brandt, and A. Richmond. 1997. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int. J. Cancer. 73:94-103.
30. Nanney, L.B., S.G. Mueller, R. Bueno, S.C. Peiper, and A. Richmond. 1995. Distributions of melanoma growth stimulatory activity or growth-related gene and the interleukin-8 receptor type B in human wound repair. Am. J. Pathol. 147:1248-1260.
31. Macchiarini, P., G. Fontanini, M.J. Hardin, F. Squartini, and C.A. Angeletti. 1992. Relation of neovascularization to metastasis of non-small cell lung cancer. Lancet (N. Am. Ed.). 340:145-146.
32. Harpole, D.H., Jr., W.G. Richards, J.E. Herndon, and D.J. Sugarbaker. 1996. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg. 61:1470-1476.